Virpax Pharmaceuticals, Inc.
VRPXDelisted Jul 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708331
Virpax Pharmaceuticals, Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 10, 2024; 7 institutions reported holding it in 13F filings for Q1 2025, worth $34.9K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Virpax Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 5 | 7 | +2 |
| Shares | 275.1K | 245.6K | −29.4K (−10.7%) |
| Value | $1.29M | $1.12M | −$178.0K (−13.7%) |
New holders (3)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 23,625 | $107.0K | 0.01% |
| Morgan Stanley | 716 | $3.00K | 0.00% |
| Wells Fargo & Company | 11 | $0 | 0.00% |
Sold out (1)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Advisor Group Holdings, Inc. | 89 | $0 |